Preemptive Therapy for Hepatitis C Virus after Living-Donor Liver Transplantation
Yasuhiko Sugawara(Kumamoto University), Norihiro Kokudo(National Center for Global Health and Medicine), Masatoshi Makuuchi(Nagano Children's Hospital), Yuichi Matsui(The University of Tokyo), Nobuhisa Akamatsu, Junichi Kaneko(University of Tokyo Hospital), Yoji Kishi(National Cancer Center Hospital East)
Cited by 112
Related Papers
Posthepatectomy liver failure: A definition and grading by the International Study Group of Liver Surgery (ISGLS)
|Surgery|2011|2.3k
Bile leakage after hepatobiliary and pancreatic surgery: A definition and grading of severity by the International Study Group of Liver Surgery
|Surgery|2011|1.9k
Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy
|Journal of Hepatology|2003|1.6k
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
|The Lancet Oncology|2015|1.1k
Ultrasonically guided subsegmentectomy.
|PubMed|1985|823